{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:27Z","timestamp":1791389007582,"version":"4.3.3"},"reference-count":221,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Hyperkinetic movement disorders are characterized by the presence of abnormal involuntary movements, comprising most notably dystonia, chorea, myoclonus, and tremor. Possible causes are numerous, including autoimmune disorders, infections of the central nervous system, metabolic disturbances, genetic diseases, drug-related causes and functional disorders, making the diagnostic process difficult for clinicians. Some diagnoses may be delayed without serious consequences, but diagnosis delays may prove detrimental in treatable disorders, ranging from functional disabilities, as in dopa-responsive dystonia, to death, as in Whipple's disease. In this review, we focus on treatable disorders that may present with prominent hyperkinetic movement disorders.<\/jats:p>","DOI":"10.3389\/fneur.2021.659805","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T23:34:13Z","timestamp":1638401653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Treatable Hyperkinetic Movement Disorders Not to Be Missed"],"prefix":"10.3389","volume":"12","author":[{"given":"Aur\u00e9lie","family":"M\u00e9neret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Garcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Frismand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Lannuzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise-Laure","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3389\/fneur.2018.01001","article-title":"Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy","volume":"9","author":"Fleetwood","year":"2018","journal-title":"Front Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"120","author":"Baizabal-Carvallo","year":"2013","journal-title":"J Neural Transm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: an update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J Neurol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.thromres.2020.10.010","article-title":"Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management","volume":"198","author":"Sayar","year":"2021","journal-title":"Thromb Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/jnnp-2016-314475","article-title":"Autoimmune choreas","volume":"88","author":"Cardoso","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mds.20262","article-title":"Paroxysmal non-kinesigenic dyskinesia in antiphospholipid syndrome","volume":"20","author":"Engelen","year":"2005","journal-title":"Mov Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/mds.23071","article-title":"Movement disorders and pregnancy: a review of the literature","volume":"25","author":"Kranick","year":"2010","journal-title":"Mov Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1002\/mds.23863","article-title":"Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies","volume":"26","author":"Reiner","year":"2011","journal-title":"Mov Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/practneurol-2017-001824","article-title":"Oromandibular chorea in antiphospholipid syndrome","volume":"18","author":"Zhang","year":"2018","journal-title":"Pract Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/biomedicines8110508","article-title":"Management of antiphospholipid syndrome","volume":"8","author":"Ghembaza","year":"2020","journal-title":"Biomedicines."},{"key":"B12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neurol.2018.07.006","article-title":"Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes","volume":"174","author":"Honnorat","year":"2018","journal-title":"Rev Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain."},{"key":"B15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/mdc3.12629","article-title":"Pragmatic treatment of stiff person spectrum disorders","volume":"5","author":"Balint","year":"2018","journal-title":"Mov Disord Clin Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/jnnp.74.4.462","article-title":"Specific phobia is a frequent non-motor feature in stiff man syndrome","volume":"74","author":"Henningsen","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mdc3.12911","article-title":"Pseudoagoraphobia, a diagnostic clue in stiff-limb syndrome","volume":"7","author":"Marano","year":"2020","journal-title":"Mov Disord Clin Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/s00415-011-6074-1","article-title":"Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience","volume":"258","author":"Vigliani","year":"2011","journal-title":"J Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1212\/NXI.0000000000001009","article-title":"Delayed benefit from aggressive immunotherapy in waxing and waning anti-IgLON5 disease","volume":"8","author":"Shambrook","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202001070","article-title":"Celiac disease","volume":"172","author":"Rubin","year":"2020","journal-title":"Ann Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: a comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/nu10081034","article-title":"Movement disorders related to gluten sensitivity: a systematic review","volume":"10","author":"Vinagre-Arag\u00f3n","year":"2018","journal-title":"Nutrients."},{"key":"B25","unstructured":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2053-8871-1-11","article-title":"Myoclonus ataxia and refractory coeliac disease","volume":"1","author":"Sarrigiannis","year":"2014","journal-title":"Cerebellum Ataxias."},{"key":"B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.parkreldis.2018.06.008","article-title":"Movement disorders in non-encephalopathic hashimoto's thyroiditis","volume":"55","author":"Miranda","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rdc.2017.06.002","article-title":"Neurologic manifestations of primary sj\u00f6gren syndrome","volume":"43","author":"Margaretten","year":"2017","journal-title":"Rheum Dis Clin North Am."},{"key":"B29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.pediatrneurol.2015.02.021","article-title":"Chorea as the initial manifestation of sj\u00f6gren syndrome","volume":"52","author":"Delorme","year":"2015","journal-title":"Pediatric Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"101906","DOI":"10.1016\/j.msard.2019.101906","article-title":"Neuro-Behcet's disease: an update on diagnosis, differential diagnoses, and treatment","volume":"39","author":"Borhani-Haghighi","year":"2020","journal-title":"Mult Scl Rel Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.autrev.2015.11.011","article-title":"Beh\u00e7et disease presenting with movement disorders and antibasal ganglia antibodies","volume":"15","author":"Rizzo","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-1331.2011.03469.x","article-title":"A clinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology: secondary movement disorders","volume":"19","author":"Netravathi","year":"2012","journal-title":"Eur J Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/B978-0-444-52014-2.00025-2","article-title":"Hyperkinetic movement disorders associated with HIV and other viral infections","volume":"100","author":"Carroll","year":"2011","journal-title":"Handbook Clin Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","article-title":"Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load","volume":"26","author":"Peluso","year":"2012","journal-title":"AIDS."},{"key":"B35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1212\/WNL.50.2.568","article-title":"Chorea as a form of presentation of human immunodeficiency virus-associated dementia complex","volume":"50","author":"Pardo","year":"1998","journal-title":"Neurology."},{"key":"B36","first-page":"109","article-title":"Paroxysmal dyskinesias in patients with HIV infection","volume-title":"Neurology.","author":"Mirsattari","year":"1999"},{"key":"B37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000138963","article-title":"Brueghel syndrome as a new manifestation of HIV encephalopathy","volume":"60","author":"Wicki","year":"2008","journal-title":"Eur Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/mds.870120418","article-title":"AIDS dementia complex with generalized myoclonus","volume":"12","author":"Maher","year":"1997","journal-title":"Mov Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00415-005-0626-1","article-title":"HIV?","volume":"252","author":"Sporer","year":"2005","journal-title":"J Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000085507","article-title":"Posterior fossa tremor induced by HIV-associated progressive multifocal leukoencephalopathy","volume":"53","author":"Sporer","year":"2005","journal-title":"Eur Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S2055-6640(20)30007-8","article-title":"Chorea associated with persistent low-level viremia in a patient living with HIV: a case report","volume":"6","author":"Rajakaruna","year":"2020","journal-title":"J Virus Erad."},{"key":"B42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0035-3787(06)74986-4","article-title":"Mouvements chor\u00e9iques r\u00e9solutifs sous traitement anti-r\u00e9troviral au cours d'une enc\u00e9phalite \u00e0 VIH","volume":"162","author":"Trocello","year":"2006","journal-title":"Rev Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.coph.2020.09.003","article-title":"Pharmacologic approaches to HIV-associated neurocognitive disorders","volume":"54","author":"Avedissian","year":"2020","journal-title":"Curr Opin Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1055\/s-0039-1688915","article-title":"Treatment of central nervous system manifestations of HIV in the current era","volume":"39","author":"Handoko","year":"2019","journal-title":"Semin Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.parkreldis.2004.03.001","article-title":"Movement disorders and AIDS: a review","volume":"10","author":"Tse","year":"2004","journal-title":"Parkin Rel Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/157.1.1","article-title":"Toxoplasmic encephalitis","volume":"157","author":"Luft","year":"1988","journal-title":"J Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1590\/S0004-282X2000000500030","article-title":"Hemicor\u00e9ia-hemibalismo associado a granuloma criptoc\u00f3cico em paciente com SIDA: relato de caso","volume":"58","author":"Teive","year":"2000","journal-title":"Arq Neuro-Psiquiatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/mds.870100423","article-title":"Hemichorea due to cryptococcal meningitis","volume":"10","author":"Weeks","year":"1995","journal-title":"Mov Disord."},{"key":"B49","first-page":"153","article-title":"[A case of hemiballismus during cryptococcal meningitis]","volume":"146","author":"Namer","year":"1990","journal-title":"Rev Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0956462414564608","article-title":"Hemichorea in a patient with HIV-associated central nervous system histoplasmosis","volume":"27","author":"Estrada-Bellmann","year":"2016","journal-title":"Int J Std AIDS."},{"key":"B51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2017.06.009","article-title":"Parkinsonism and other movement disorders in 23 cases of neurocysticercosis","volume":"42","author":"Alarc\u00f3n","year":"2017","journal-title":"Parkins Rel Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014","journal-title":"Lancet Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/mds.27419","article-title":"Systematic review of movement disorders and oculomotor abnormalities in Whipple's disease","volume":"33","author":"Bally","year":"2018","journal-title":"Mov Disord."},{"key":"B54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jns.2017.01.048","article-title":"Whipple's disease","volume":"377","author":"El-Abassi","year":"2017","journal-title":"J Neurol Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.26093","article-title":"Myorhythmia: phenomenology, etiology, and treatment","volume":"30","author":"Baizabal-Carvallo","year":"2015","journal-title":"Mov Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jinf.2014.05.008","article-title":"Tropheryma whipplei and Whipple's disease","volume":"69","author":"Fenollar","year":"2014","journal-title":"J Infect."},{"key":"B57","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mds.24950","article-title":"Acquired neurosyphilis presenting as movement disorders: movement disorders in acquired neurosyphilis","volume":"27","author":"Shah","year":"2012","journal-title":"Mov Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/mds.24952","article-title":"A case of neurosyphilis presenting with myoclonus, cerebellar ataxia, and speech disturbance","volume":"27","author":"Shah","year":"2012","journal-title":"Mov Disord."},{"key":"B59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5334\/tohm.365","article-title":"Orofacial involuntary movements in neurosyphilis: beyond the candy sign","volume":"7","author":"Lenka","year":"2017","journal-title":"Tremor Other Hyperk Mov."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1212\/WNL.0000000000003544","article-title":"Teaching video neuro Images : candy sign: the clue to the diagnosis of neurosyphilis","volume":"88","author":"Marto","year":"2017","journal-title":"Neurology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","article-title":"2020 European guideline on the management of syphilis","volume":"35","author":"Janier","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/1531-8257(200005)15:3","article-title":"Movement disorders in 30 patients with tuberculous meningitis","volume":"15","author":"Alarc\u00f3n","year":"2000","journal-title":"Mov Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.11604\/pamj.2019.33.2.13327","article-title":"A case of bilateral thalamic infarct complicating tuberculous meningoencephalitis","volume":"33","author":"Aasfara","year":"2019","journal-title":"Pan Afr Med J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(18)33131-3","article-title":"Tetanus","volume":"393","author":"Yen","year":"2019","journal-title":"Lancet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jcrc.2017.12.025","article-title":"Clinical features and outcomes of tetanus: analysis using a national inpatient database in Japan","volume":"44","author":"Nakajima","year":"2018","journal-title":"J Crit Care."},{"key":"B66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/toxins5010073","article-title":"Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms","volume":"5","author":"Hassel","year":"2013","journal-title":"Toxins."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1097\/INF.0000000000001205","article-title":"Anti-N-Methyl-D-aspartate receptor antibody mediated neurologic relapse post herpes simplex encephalitis: a case series","volume":"35","author":"Geoghegan","year":"2016","journal-title":"Pediat Infect Dis J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti -D -aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev Med Child Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"456","DOI":"10.5334\/tohm.376","article-title":"Treatment of sydenham's chorea: a review of the current evidence","volume":"7","author":"Dean","year":"2017","journal-title":"Tremor Other Hyperk Mov."},{"key":"B71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0045-2018","article-title":"Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group a streptococci and their sequelae","volume":"7","author":"Cunningham","year":"2019","journal-title":"Microbiol Spect."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the infectious diseases society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1089\/cap.2018.0151","article-title":"Clinical-serological characterization and treatment outcome of a large cohort of italian children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection and pediatric acute neuropsychiatric syndrome","volume":"29","author":"Lepri","year":"2019","journal-title":"J Child Adol Psychopharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1089\/cap.2016.0151","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome: Part III\u2014treatment and prevention of infections","volume":"27","year":"2017","journal-title":"J Child Adol Psychopharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1089\/cap.2017.0042","article-title":"Overview of treatment of pediatric acute-onset neuropsychiatric syndrome","volume":"27","author":"Swedo","year":"2017","journal-title":"J Child Adol Psychopharmacol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry."},{"key":"B77","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/13651501.2017.1285941","article-title":"An expert opinion on PANDAS\/PANS: highlights and controversies","volume":"21","author":"Chiarello","year":"2017","journal-title":"Int J Psychiatry Clin Practice."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","article-title":"Update on opsoclonus\u2013myoclonus syndrome in adults","volume":"266","author":"Oh","year":"2019","journal-title":"J Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","article-title":"Update on diagnosis, treatment, and prognosis in opsoclonus\u2013myoclonus\u2013ataxia syndrome","volume":"22","author":"Gorman","year":"2010","journal-title":"Curr Opin Pediatr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","article-title":"Adult-onset opsoclonus-myoclonus syndrome","volume":"69","author":"Klaas","year":"2012","journal-title":"Arch Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/0883073820911327","article-title":"Infection-associated opsoclonus: a retrospective case record analysis and review of literature","volume":"35","author":"Saini","year":"2020","journal-title":"J Child Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1111\/ene.14726","article-title":"Acute cerebellar ataxia and myoclonus with or without opsoclonus: a parainfectious syndrome associated with COVID-19","volume":"28","author":"Foucard","year":"2021","journal-title":"Eur J Neurol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13365-017-0603-3","article-title":"HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review","volume":"24","author":"Guedes","year":"2018","journal-title":"J Neurovirol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"585527","DOI":"10.3389\/fneur.2020.585527","article-title":"CSF HIV RNA escape in opsoclonus-myoclonus-ataxia syndrome: case report and review of the literature","volume":"11","author":"Pierre","year":"2020","journal-title":"Front Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejpn.2017.11.010","article-title":"Principles and approaches to the treatment of immune-mediated movement disorders","volume":"22","author":"Mohammad","year":"2018","journal-title":"Eur J Paediatric Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/brainsci7080103","article-title":"Myoclonic disorders","volume":"7","author":"Eberhardt","year":"2017","journal-title":"Brain Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/mds.10037","article-title":"Orofacial dyskinesias in a patient with primary biliary cirrhosis: a clinicopathological case report and review","volume":"17","author":"Thobois","year":"2002","journal-title":"Mov Disord."},{"key":"B88","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5334\/tohm.379","article-title":"Recent updates on acquired hepatocerebral degeneration","volume":"7","author":"Shin","year":"2017","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"B89","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.475","article-title":"Uncommon movement disorders in chronic hepatic disease with response to rifaximin","volume-title":"Tremor Other Hyperkinet Mov.","author":"Sousa","year":"2019"},{"key":"B90","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1053\/j.ajkd.2013.08.030","article-title":"A syndrome of bilateral symmetrical basal ganglia lesions in diabetic dialysis patients","volume":"63","author":"Finelli","year":"2014","journal-title":"Am J Kidney Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41598-020-58555-w","article-title":"Diabetic striatopathy: clinical presentations, controversy, pathogenesis, treatments, and outcomes","volume":"10","author":"Chua","year":"2020","journal-title":"Sci Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10072-014-1968-1","article-title":"Chorea-ballism associated with ketotic hyperglycemia","volume":"35","author":"Chen","year":"2014","journal-title":"Neurol Sci."},{"key":"B93","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2019-002277","article-title":"Emergency presentations of movement disorders","volume-title":"Pract Neurol.","author":"Gandhi","year":"2020"},{"key":"B94","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0002-9343(99)00021-2","article-title":"Neuroglycopenic and other symptoms in patients with insulinomas","volume":"106","author":"Dizon","year":"1999","journal-title":"Am J Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000268166","article-title":"Neuropsychiatric profiles of patients with insulinomas","volume":"63","author":"Ding","year":"2010","journal-title":"Eur Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ana.410240419","article-title":"Idiopathic hypoparathyroidism and paroxysmal dystonic choreoathetosis","volume":"24","author":"Barabas","year":"1988","journal-title":"Ann Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/mds.870130424","article-title":"Paroxysmal dyskinesia in a patient with pseudohypoparathyroidism","volume":"13","author":"Dure","year":"1998","journal-title":"Mov Disord."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1056\/NEJMicm074227","article-title":"Chvostek's sign and carpopedal spasm","volume":"360","author":"Athappan","year":"2009","journal-title":"N Engl J Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/B978-0-7020-4087-0.00049-8","article-title":"Neurologic disorders of mineral metabolism and parathyroid disease","volume":"120","author":"Agrawal","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0011-5029(88)90013-2","article-title":"Magnesium metabolism in health and disease","volume":"34","author":"Elin","year":"1988","journal-title":"Dis Mon."},{"key":"B101","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/B978-0-7020-4086-3.00023-0","article-title":"Neurologic complications of electrolyte disturbances and acid-base balance","volume":"119","author":"Espay","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/mdc3.13057","article-title":"Paroxysmal tremor and vertical nystagmus associated with hypomagnesemia","volume":"7","author":"Marse","year":"2020","journal-title":"Mov Disord Clin Pract."},{"key":"B103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000115674","article-title":"Chorea and polycythaemia","volume":"23","author":"Bruyn","year":"1984","journal-title":"Eur Neurol."},{"key":"B104","unstructured":"Late-Onset Chorea in JAK2-Associated Essential Thrombocythemia - Koya Kutty - 2021 - Movement Disorders Clinical Practice - Wiley Online Library."},{"key":"B105","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-0-444-52014-2.00019-7","article-title":"Polycythemia and chorea","volume":"100","author":"Marvi","year":"2011","journal-title":"Handb Clin Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11910-019-0921-3","article-title":"Movement disorders in metabolic disorders","volume":"19","author":"Pedroso","year":"2019","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/mds.20883","article-title":"Movement disorders associated with hyperthyroidism: expanding the phenotype","volume":"21","author":"Tan","year":"2006","journal-title":"Mov Disord."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-020-01314-5","article-title":"Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors","volume":"44","author":"Mohammadi","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s00415-009-5314-0","article-title":"Choreathetosis due to abuse of levothyroxine","volume":"256","author":"Kondziella","year":"2009","journal-title":"J Neurol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/0009922806290104","article-title":"Titubation and paroxysmal dyskinesia: an unusual presentation of hypothyroidism","volume":"46","author":"Hopkins","year":"2007","journal-title":"Clin Pediatr."},{"key":"B111","first-page":"102","article-title":"Paroxysmal kinesigenic dyskinesia manifestation of hyperthyroidism","volume":"52","author":"Puri","year":"2004","journal-title":"Neurol India."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1179\/1743132814Y.0000000396","article-title":"Involuntary movements due to vitamin B12 deficiency","volume":"36","author":"de","year":"2014","journal-title":"Neurol Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/B978-0-7020-4087-0.00060-7","article-title":"Neurologic aspects of cobalamin (B12) deficiency","volume":"120","author":"Kumar","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","article-title":"Expanding the spectrum of genes involved in huntington disease using a combined clinical and genetic approach","volume":"73","author":"Mariani","year":"2016","journal-title":"JAMA Neurol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S1474-4422(05)70226-X","article-title":"Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study","volume":"4","author":"Wenning","year":"2005","journal-title":"Lancet Neurol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/archdischild-2017-314464","article-title":"Acute hyperkinetic movement disorders in Italian paediatric emergency departments","volume":"103","author":"Raucci","year":"2018","journal-title":"Arch Dis Child."},{"key":"B117","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1474-4422(19)30152-8","article-title":"Recent developments in drug-induced movement disorders: a mixed picture","volume":"18","author":"Factor","year":"2019","journal-title":"Lancet Neurol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/1570159X13666150115220221","article-title":"The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: a meta-analysis","volume":"13","author":"Thomas","year":"2015","journal-title":"Curr Neuropharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.archger.2007.05.008","article-title":"Prevalence of movement disorders in an elderly nursing home population","volume":"46","author":"Tse","year":"2008","journal-title":"Arch Gerontol Geriatr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s40264-014-0219-y","article-title":"The safety of olanzapine in young children: a systematic review and meta-analysis","volume":"37","author":"Flank","year":"2014","journal-title":"Drug Saf."},{"key":"B121","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s40264-016-0418-9","article-title":"The safety of metoclopramide in children: a systematic review and meta-analysis","volume":"39","author":"Lau","year":"2016","journal-title":"Drug Saf."},{"key":"B122","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1586\/ern.10.58","article-title":"Tardive dyskinesia and withdrawal emergent syndrome in children","volume":"10","author":"Mejia","year":"2010","journal-title":"Expert Rev Neurother."},{"key":"B123","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40263-019-00625-3","article-title":"Medication-induced akathisia with newly approved antipsychotics in patients with a severe mental illness: a systematic review and meta-analysis","volume":"33","author":"Demyttenaere","year":"2019","journal-title":"CNS Drugs."},{"key":"B124","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jns.2018.02.008","article-title":"The nosology of tardive syndromes","volume":"389","author":"Frei","year":"2018","journal-title":"J Neurol Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12612-012-0264-z","article-title":"Syndromes parkinsoniens et mouvements involontaires m\u00e9dicamenteux dans la population \u00e2g\u00e9e","volume":"4","author":"Bonnet","year":"2012","journal-title":"Les Cahiers Ann\u00e9e G\u00e9rontol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40266-018-0590-y","article-title":"Current methods for the treatment and prevention of drug-induced parkinsonism and tardive dyskinesia in the elderly","volume":"35","author":"Estevez-Fraga","year":"2018","journal-title":"Drugs Aging."},{"key":"B127","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40265-016-0568-1","article-title":"Drug-induced dyskinesia, part 2: treatment of tardive dyskinesia","volume":"76","author":"Vijayakumar","year":"2016","journal-title":"Drugs."},{"key":"B128","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40263-018-0559-8","article-title":"Antipsychotic-associated symptoms of tourette syndrome: a systematic review","volume":"32","author":"Kim","year":"2018","journal-title":"CNS Drugs."},{"key":"B129","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/YIC.0b013e32834aa924","article-title":"Tardive tourette-like syndrome: a systematic review","volume":"26","author":"Fountoulakis","year":"2011","journal-title":"Int Clin Psychopharmacol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mds.870130317","article-title":"Hyperkinetic movement disorders misdiagnosed as tics in gilles de la tourette syndrome","volume":"13","author":"Kompoliti","year":"1998","journal-title":"Mov Disord."},{"key":"B131","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2018.02.005","article-title":"Tardive syndromes","volume":"389","author":"Savitt","year":"2018","journal-title":"J Neurol Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1192\/bjp.171.2.148","article-title":"Incidence and risk factors for severe tardive dyskinesia in older patients","volume":"171","author":"Caligiuri","year":"1997","journal-title":"Br J Psychiatry."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis","volume":"78","author":"Carbon","year":"2017","journal-title":"J Clin Psychiatry."},{"key":"B134","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/archpsyc.1995.03950210050010","article-title":"Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients","volume":"52","author":"Jeste","year":"1995","journal-title":"Arch Gen Psychiatry."},{"key":"B135","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10072-016-2771-y","article-title":"Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype","volume":"38","author":"Munhoz","year":"2017","journal-title":"Neurol Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0006-3223(95)00082-8","article-title":"Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation","volume":"38","author":"Schultz","year":"1995","journal-title":"Biol Psychiatry."},{"key":"B137","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000477313","article-title":"Antipsychotic-Induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy","volume":"86","author":"Chouinard","year":"2017","journal-title":"Psychother Psychosom."},{"key":"B138","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40263-013-0079-5","article-title":"Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations","volume":"27","author":"Cerovecki","year":"2013","journal-title":"CNS Drugs."},{"key":"B139","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00002826-198406000-00006","article-title":"The reversibility of \u201cpermanent\u201d tardive dyskinesia","volume":"7","author":"Klawans","year":"1984","journal-title":"Clin Neuropharmacol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/JCP.0000000000001114","article-title":"Long-term response to clozapine and its clinical correlates in the treatment of tardive movement syndromes: a naturalistic observational study in patients with psychotic disorders","volume":"39","author":"Lee","year":"2019","journal-title":"J Clin Psychopharmacol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12888-020-02748-0","article-title":"Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia","volume":"20","author":"Caroff","year":"2020","journal-title":"BMC Psychiatry."},{"key":"B142","doi-asserted-by":"publisher","first-page":"CD000459","DOI":"10.1002\/14651858.CD000459.pub3","article-title":"Antipsychotic reduction and\/or cessation and antipsychotics as specific treatments for tardive dyskinesia","volume":"2","author":"Bergman","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B143","doi-asserted-by":"publisher","first-page":"493","DOI":"10.9758\/cpn.2020.18.4.493","article-title":"Recent advances in the pharmacology of tardive dyskinesia","volume":"18","author":"Caroff","year":"2020","journal-title":"Clin Psychopharmacol Neurosci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5334\/tohm.199","article-title":"Tardive syndromes are rarely reversible after discontinuing dopamine receptor blocking agents: experience from a university-based movement disorder clinic","volume":"4","author":"Zutshi","year":"2014","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"B145","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0706743719828968","article-title":"Treatment recommendations for tardive dyskinesia","volume":"64","author":"Ricciardi","year":"2019","journal-title":"Can J Psychiatry."},{"key":"B146","doi-asserted-by":"publisher","first-page":"CD000203","DOI":"10.1002\/14651858.CD000203.pub4","article-title":"Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia","volume":"4","author":"Alabed","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B147","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1212\/WNL.0000000000002370","article-title":"Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia","volume":"86","author":"Pouclet-Courtemanche","year":"2016","journal-title":"Neurology."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.brs.2018.08.006","article-title":"Neurostimulation in tardive dystonia\/dyskinesia: a delayed start, sham stimulation-controlled randomized trial","volume":"11","author":"Gruber","year":"2018","journal-title":"Brain Stimul."},{"key":"B149","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2018.02.013","article-title":"Deep brain stimulation for tardive syndromes: systematic review and meta-analysis","volume":"389","author":"Macerollo","year":"2018","journal-title":"J Neurol Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1212\/WNL.0b013e31829d86b6","article-title":"Evidence-based guideline: treatment of tardive syndromes: report of the guideline development subcommittee of the american academy of neurology","volume":"81","author":"Bhidayasiri","year":"2013","journal-title":"Neurology."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s13311-020-00914-6","article-title":"Current management of tics and tourette syndrome: behavioral, pharmacologic, and surgical treatments","volume":"17","author":"Billnitzer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B152","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","article-title":"Comprehensive systematic review summary: treatment of tics in people with tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim","year":"2019","journal-title":"Neurology."},{"key":"B153","doi-asserted-by":"publisher","first-page":"570","DOI":"10.5334\/tohm.438","article-title":"Tardive dyskinesia-like syndrome due to drugs that do not block dopamine receptors: rare or non-existent: literature review","volume":"8","author":"D'Abreu","year":"2018","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"B154","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2020.08.031","article-title":"Movement disorders induced by psychiatric drugs that do not block dopamine receptors","volume":"79","author":"Friedman","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/archpsyc.1980.01780250054006","article-title":"Changes in prevalence, severity, and recovery in tardive dyskinesia with age","volume":"37","author":"Smith","year":"1980","journal-title":"Arch Gen Psychiatry."},{"key":"B156","first-page":"162","article-title":"Medication-induced tardive dyskinesia: a review and update","volume":"17","author":"Cornett","year":"2017","journal-title":"Ochsner J."},{"key":"B157","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/JCP.0000000000000344","article-title":"Serotonin syndrome: analysis of cases registered in the french pharmacovigilance database","volume":"35","author":"Abadie","year":"2015","journal-title":"J Clin Psychopharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3390\/ijms20092288","article-title":"The serotonin syndrome: from molecular mechanisms to clinical practice","volume":"20","author":"Francescangeli","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1192\/bjp.bp.107.048371","article-title":"Antidepressant-induced jitteriness\/anxiety syndrome: systematic review","volume":"194","author":"Sinclair","year":"2009","journal-title":"Br J Psychiatry."},{"key":"B160","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40261-017-0598-9","article-title":"Lithium toxicity in older adults: a systematic review of case reports","volume":"38","author":"Sun","year":"2018","journal-title":"Clin Drug Investig."},{"key":"B161","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","article-title":"Drug-induced tremors","volume":"4","author":"Morgan","year":"2005","journal-title":"Lancet Neurol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/WNF.0000000000000387","article-title":"Carbamazepine-, oxcarbazepine-, eslicarbazepine-associated movement disorder: a literature review","volume":"43","author":"Rissardo","year":"2020","journal-title":"Clin Neuropharmacol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e2734","DOI":"10.1002\/hup.2734","article-title":"Drug-induced tics: an observational postmarketing study","volume":"35","author":"Touafchia","year":"2020","journal-title":"Hum Psychopharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4103\/tcmj.tcmj_13_20","article-title":"Mirtazapine-associated movement disorders: a literature review","volume":"32","author":"Rissardo","year":"2020","journal-title":"Tzu Chi Med J."},{"key":"B165","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/B978-0-12-411546-0.00016-0","article-title":"Tics and other stereotyped movements as side effects of pharmacological treatment","volume":"112","author":"Madruga-Garrido","year":"2013","journal-title":"Int Rev Neurobiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00415-016-8357-z","article-title":"The clinical heterogeneity of drug-induced myoclonus: an illustrated review","volume":"264","author":"Janssen","year":"2017","journal-title":"J Neurol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1212\/WNL.44.4.751","article-title":"Cocaine-induced choreoathetoid movements ('crack dancing')","volume":"44","author":"Daras","year":"1994","journal-title":"Neurology."},{"key":"B168","doi-asserted-by":"publisher","first-page":"4318450","DOI":"10.1155\/2017\/4318450","article-title":"SSRI facilitated crack dancing","volume":"2017","author":"Doobay","year":"2017","journal-title":"Case Rep Neurol Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/mds.21430","article-title":"Crack dancing in the United Kingdom: apropos a video case presentation","volume":"22","author":"Kamath","year":"2007","journal-title":"Mov Disord."},{"key":"B170","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fneur.2015.00075","article-title":"Psychostimulants and movement disorders","volume":"6","author":"Asser","year":"2015","journal-title":"Front Neurol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neurol.2016.07.005","article-title":"Paroxysmal movement disorders: an update","volume":"172","author":"Meneret","year":"2016","journal-title":"Rev Neurol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/ene.12104","article-title":"PRRT2 mutations and paroxysmal disorders","volume":"20","author":"Meneret","year":"2013","journal-title":"Eur J Neurol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.seizure.2016.02.009","article-title":"Lamotrigine monotherapy for paroxysmal kinesigenic dyskinesia in children","volume":"37","author":"Li","year":"2016","journal-title":"Seizure."},{"key":"B174","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2020.06.017","article-title":"Zonisamide therapy for patients with paroxysmal kinesigenic dyskinesia","volume":"111","author":"Matsuura","year":"2020","journal-title":"Pediatric Neurol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/jnnp.47.8.885","article-title":"Kinesigenic foot dystonia as a presenting feature of Parkinson's disease","volume":"47","author":"Lees","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B176","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mds.26494","article-title":"ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias","volume":"31","author":"Friedman","year":"2016","journal-title":"Mov Dis."},{"key":"B177","doi-asserted-by":"crossref","DOI":"10.7326\/L19-0038","article-title":"Caffeine and the dyskinesia related to mutations in the ADCY5 gene","volume-title":"Ann Intern Med","author":"M\u00e9neret","year":"2019"},{"key":"B178","doi-asserted-by":"publisher","first-page":"238","DOI":"10.14802\/jmd.20014","article-title":"Recurrent ADCY5 mutation in mosaic form with nocturnal paroxysmal dyskinesias and video electroencephalography documentation of dramatic response to caffeine treatment","volume":"13","author":"Shetty","year":"2020","journal-title":"J Mov Disord."},{"key":"B179","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/mds.22313","article-title":"Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients","volume":"23","author":"Gitiaux","year":"2008","journal-title":"Mov Disord."},{"key":"B180","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neurol.2013.09.005","article-title":"GLUT1 deficiency syndrome: an update","volume":"170","author":"Gras","year":"2014","journal-title":"Rev Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/14737175.2021.1840978","article-title":"Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders","volume":"21","author":"Delorme","year":"2021","journal-title":"Expert Rev Neurother."},{"key":"B182","article-title":"Glucose transporter type 1 deficiency syndrome","volume-title":"GeneReviews\u00ae","author":"Wang","year":"2021"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/jnnp-2018-320283","article-title":"Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect","volume":"90","author":"Hainque","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B184","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/jnnp-2015-311475","article-title":"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency","volume":"87","author":"Mochel","year":"2016","journal-title":"J Neurol Neuro Psychiatry"},{"key":"B185","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/jnnp-2019-321694","article-title":"Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome","volume":"91","author":"Hainque","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awp084","article-title":"Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia","volume":"132","author":"Clot","year":"2009","journal-title":"Brain."},{"key":"B187","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J Neurol Neuro Psychiatry."},{"key":"B188","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mds.26910","article-title":"Oculogyric crises: a review of phenomenology, etiology, pathogenesis, and treatment","volume":"32","author":"Slow","year":"2017","journal-title":"Mov Disord."},{"key":"B189","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/brain\/awy331","article-title":"Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency","volume":"142","author":"Kojima","year":"2019","journal-title":"Brain."},{"key":"B190","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1469-8749.2009.03541.x","article-title":"Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis","volume":"52","author":"Barnerias","year":"2010","journal-title":"Dev Med Child Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1212\/WNL.0000000000004689","article-title":"Pyruvate dehydrogenase complex-E2 deficiency causes paroxysmal exercise-induced dyskinesia","volume":"89","author":"Friedman","year":"2017","journal-title":"Neurology."},{"key":"B192","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13023-020-01586-3","article-title":"Pyruvate dehydrogenase complex deficiency: updating the clinical, metabolic and mutational landscapes in a cohort of portuguese patients","volume":"15","author":"Pavlu-Pereira","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B193","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ejpn.2015.04.008","article-title":"Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation. Case report and mini-review","volume":"19","author":"Castiglioni","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ejpn.2009.11.001","article-title":"Pyruvate dehydrogenase E2 deficiency: a potentially treatable cause of episodic dystonia","volume":"14","author":"McWilliam","year":"2010","journal-title":"Eur J Paediatric Neurol."},{"key":"B195","article-title":"Glutaric acidemia type 1","volume-title":"GeneReviews\u00ae","author":"Larson","year":"2020"},{"key":"B196","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/mds.27568","article-title":"Movement disorders in treatable inborn errors of metabolism","volume":"34","author":"Ebrahimi-Fakhari","year":"2019","journal-title":"Mov Disord."},{"key":"B197","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-016-9999-9","article-title":"Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision","volume":"40","author":"Boy","year":"2017","journal-title":"J Inherit Metab Dis."},{"key":"B198","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/brain\/aws122","article-title":"Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency","volume":"135","author":"Grapp","year":"2012","journal-title":"Brain."},{"key":"B199","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ejpn.2016.05.021","article-title":"Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation","volume":"20","author":"Delmelle","year":"2016","journal-title":"Eur J Paediatr Neurol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13023-016-0419-x","article-title":"Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood","volume":"11","author":"Degos","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/mds.25206","article-title":"Myoclonus and dystonia in cerebrotendinous xanthomatosis","volume":"27","author":"Lagarde","year":"2012","journal-title":"Mov Dis."},{"key":"B202","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10545-018-0162-7","article-title":"Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes","volume":"41","author":"Amador","year":"2018","journal-title":"J Inherit Metab Dis."},{"key":"B203","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/B978-0-7020-4087-0.00057-7","article-title":"Disorders of heavy metals","volume":"120","author":"Woimant","year":"2014","journal-title":"Handbook Clin Neurol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.21037\/atm.2019.02.10","article-title":"Challenges in the diagnosis of Wilson disease","volume":"7","author":"Poujois","year":"2019","journal-title":"Ann Transl Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"e2189","DOI":"10.1212\/WNL.0000000000009474","article-title":"Liver transplantation as a rescue therapy for severe neurologic forms of Wilson disease","volume":"94","author":"Poujois","year":"2020","journal-title":"Neurology."},{"key":"B206","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awl260","article-title":"The adult form of niemann-pick disease type C","volume":"130","author":"Sevin","year":"2007","journal-title":"Brain."},{"key":"B207","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1750-1172-8-166","article-title":"Niemann-Pick disease type C symptomatology: an expert-based clinical description","volume":"8","author":"Mengel","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B208","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-020-01363-2","article-title":"Treatment outcomes following continuous miglustat therapy in patients with niemann-pick disease type C: a final report of the NPC registry","volume":"15","author":"Patterson","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B209","article-title":"Ataxia with vitamin E deficiency","volume-title":"GeneReviews(R)","author":"Schuelke","year":""},{"key":"B210","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5334\/tohm.298","article-title":"Ataxia with vitamin E deficiency may present with cervical dystonia","volume":"6","author":"Becker","year":"2016","journal-title":"Tremor Other Hyperk Mov."},{"key":"B211","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/archneurol.2009.293","article-title":"Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations","volume":"67","author":"Debs","year":"2010","journal-title":"Arch Neurol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","article-title":"Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings","volume":"80","author":"Tabarki","year":"2013","journal-title":"Neurology."},{"key":"B213","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1093\/brain\/aww303","article-title":"Treatable mitochondrial diseases: cofactor metabolism and beyond","volume":"140","author":"Distelmaier","year":"2017","journal-title":"Brain."},{"key":"B214","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0040-1715628","article-title":"Thiamine pyrophosphokinase deficiency due to mutations in the TPK1 gene: a rare, treatable neurodegenerative disorder","volume":"52","author":"R\u00fcsch","year":"2021","journal-title":"Neuropediatrics."},{"key":"B215","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1750-1172-8-173","article-title":"Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression","volume":"8","author":"Mignot","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B216","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/mdc3.12667","article-title":"ADCK3-related coenzyme Q10 deficiency: a potentially treatable genetic disease","volume":"5","author":"Chang","year":"2018","journal-title":"Mov Disord Clin Pract."},{"key":"B217","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ajhg.2012.01.017","article-title":"Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease","volume":"90","author":"Quadri","year":"2012","journal-title":"Am J Human Gen."},{"key":"B218","doi-asserted-by":"publisher","first-page":"117101","DOI":"10.1016\/j.jns.2020.117101","article-title":"A novel SLC30A10 missense variant associated with parkinsonism and dystonia without hypermanganesemia","volume":"418","author":"Lambrianides","year":"2020","journal-title":"J Neurol Sci."},{"key":"B219","article-title":"SLC39A14 deficiency.","volume-title":"GeneReviews\u00ae","author":"Tuschl","year":"2021"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","article-title":"Current concepts in diagnosis and treatment of functional neurological disorders","volume":"75","author":"Espay","year":"2018","journal-title":"JAMA Neurol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/ene.14200","article-title":"Opinions and clinical practices related to diagnosing and managing functional (psychogenic) movement disorders: changes in the last decade","volume":"27","author":"LaFaver","year":"2020","journal-title":"Eur J Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.659805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T21:54:42Z","timestamp":1673906082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.659805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":221,"alternative-id":["10.3389\/fneur.2021.659805"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.659805","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"article-number":"659805"}}